Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Lexeo Therapeutics (LXEO) Interest & Investment Income (2022 - 2023)

Lexeo Therapeutics' Interest & Investment Income history spans 2 years, with the latest figure at $1.1 million for Q4 2023.

  • For Q4 2023, Interest & Investment Income rose 63.02% year-over-year to $1.1 million; the TTM value through Dec 2023 reached $2.9 million, changed N/A, while the annual FY2024 figure was $7.6 million, 163.55% up from the prior year.
  • Interest & Investment Income for Q4 2023 was $1.1 million at Lexeo Therapeutics, up from $488000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.1 million in Q4 2023 and bottomed at $488000.0 in Q3 2023.